Immunic reported $136.42M in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
BioMarin Pharmaceutical USD 11.57B 154.21M Sep/2026
Cipla INR 434.34B 9.38B Sep/2026
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 138.36M 7.5M Jun/2026
CSL USD 37.9B 1.5B Dec/2025
Enanta Pharmaceuticals USD 329.5M 48.77M Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Immunic USD 136.42M 22.75M Sep/2026
Insmed USD 2.23B 123.49M Sep/2026
Omeros USD 200.57M 34.59M Jun/2025
OraSure Technologies USD 360.55M 18.62M Jun/2026
Quidel USD 5.78B 66M Sep/2026
Ultragenyx Pharmaceutical USD 1.19B 77M Sep/2026
United Therapeutics USD 7.03B 186M Sep/2026